Holen Sie sich die Stockscreener-App
16.92
1.28%
-0.22
Handel nachbörslich:
16.92
Schlusskurs vom Vortag:
$17.14
Offen:
$17.17
24-Stunden-Volumen:
136.32K
Relative Volume:
6.16
Marktkapitalisierung:
$673.29M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-8.98%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$16.35
$18.24
1-Wochen-Bereich:
$16.35
$20.50
52-Wochen-Spanne:
$16.35
$20.50
Zenas Biopharma Inc Stock (ZBIO) Company Profile
Firmenname
Zenas Biopharma Inc
Sektor
Branche
Telefon
-
Adresse
-
Zenas Biopharma Inc Aktie (ZBIO) Neueste Nachrichten
IgG4-related Disease Market to Show Remarkable Growth Trends - openPR
Last Week's 3 Biotech IPOs Prompt Huge Insider Buying - 24/7 Wall St.
Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN
Zenas BioPharma CEO acquires $360k worth of company shares By Investing.com - Investing.com Canada
Zenas BioPharma CEO acquires $360k worth of company shares - Investing.com
Zenas BioPharma CEO acquires $360k worth of company shares - Investing.com India
Zenas BioPharma CEO acquires $360k worth of company shares By Investing.com - Investing.com UK
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering - The Korea Bizwire
Zenas BioPharma’s $225 Million IPO - Global Legal Chronicle
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering - ForexTV.com
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase ... - The Bakersfield Californian
Zenas BioPharma Announces Closing of Full Exercise of - GlobeNewswire
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in - EIN News
Upstream Bio goes public amid spate of IPOs - The Pharma Letter
Zenas BioPharma Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in… - Informazione.it
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com South Africa
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com Australia
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com India
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com Canada
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com UK
Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com South Africa
Zenas BioPharma director acquires $999k in company stock - Investing.com Canada
Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com Australia
Zenas BioPharma director acquires $999k in company stock - Investing.com
Zenas BioPharma director acquires $999k in company stock - Investing.com India
Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com UK
Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock - Investing.com UK
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com South Africa
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com Canada
Zenas BioPharma director buys $7.48m in company stock - Investing.com
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com Australia
Zenas BioPharma director buys $7.48m in company stock - Investing.com India
Zenas BioPharma director Jason Raleigh acquires $15 million in company stock By Investing.com - Investing.com South Africa
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com UK
Zenas BioPharma director Jason Raleigh acquires $15 million in company stock - Investing.com India
Zenas BioPharma director Jason Raleigh acquires $15 million in company stock - Investing.com
Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock - Investing.com Canada
Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock - Investing.com India
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com Australia
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com Canada
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com India
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com UK
MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last? - Scrip
Biotech IPO Shares Climb in Trading Debuts After Deals Upsized - MSN
Biotech IPOs Surge on Debut: Upsized Deals Boost Shares for Drug Developers Tackling Autoimmune Diseases - Share Price India News
Trio of first-day pops may bode well for biotech IPO window - BioCentury
Biotech Startups Make Pre-Election Sprint to the Public Markets - The Wall Street Journal
2 Life Sciences Cos. Start Trading After Raising $540M Total - Law360
Biotech trio revives the IPO market - Axios
Finanzdaten der Zenas Biopharma Inc-Aktie (ZBIO)
Es liegen keine Finanzdaten für Zenas Biopharma Inc (ZBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):